Full Text
Cost-Effectiveness Analysis Of Ambrisentan Versus Bosentan In The Treatment Of Patients With Pulmonary Arterial Hypertension Functional Class III

Abstract

Authors

F. Ochoa L. Rojas M. Romero

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×